Dominic Borkelmans is the founder and editor-in-chief of Neurofounders. His work focuses on early-stage neurotechnology companies, clinical and regulatory developments, and the translation of neuroscience into deployable technologies. He holds an MSc in Applied Neuroscience from King’s College London and an MSc in Entrepreneurship from Esade Business School, and works with companies and researchers across the neurotech ecosystem.